简介：curen．治愈；痊愈怯治愈；治疗【经典例句】Thereisstillnocureforthecancer.目前仍没有治疗癌症的良药。

简介：

简介：

简介：无

简介：Inthepastthreeyears,anunprecedentedupsurgeofdemocratizationhassweptacrossthewholeAfricaandpartofAsia,andspilledovertoLatinAmericawhichwasalreadylargelydemocratizedduringthe1980s.Muchhasbeenwrittenaboutitsprocess,nature,causes,andprospects,sothispaperwouldonlyconcen-

简介：脱发areata是头发滤泡的疾病，与支持自体免疫的病原学的充分证据。脱发areata经常与象干癣和地衣planus那样的皮肤表明与调停免疫者的疾病被联系，或没有象自体免疫的甲状腺炎和自发的thrombocytopenic紫癜病那样的皮肤表明。Helicobacterpylori(H。pylori)感染在约50%世界人口是在场的并且包括自体免疫的甲状腺炎，自发的thrombocytopenic紫癜病，和干癣与许多调停免疫者的额外消化的混乱被联系了。有头皮和胡子的脱发areata的8瞬间历史的一个43年的老人的一个盒子被介绍。病人被一个皮肤学家正在对待并且有精神病学的支持，没有任何改进。他有消化不良的历史，脲呼吸测试证实了H。pylori感染。病人在H以后从脱发areata走进宽恕。pylori根除。如果如此的一个协会被为这个目的设计的流行病学的研究证实，新治疗学的选择能为这些病人是可得到的，特别在区域在哪儿有H的感染。pylori是高度流行的。

简介：无

简介：CCUR800/8000门禁控制系统特别满足了FIPS标准，还确保当重大安全事件发生时会增强安全防御．是满足现今最严苛的安防和管理需求的不二选择。另外．C-CURE800／8000支持iSTARIP门禁控制器．为任何寻求最高保护的政府或企业提供解决方案。

简介：Thepost-curekineticsofelectronbeam(EB)curingofepoxyresininitiatedbydiaryiodiniumwasinvestigated.Thepost-curereactionfitsfirstorderreactionkinetics.Thereactionrateconstantincreaseswithincreasingtreatmenttemperatureofpost-cure.Thereactionrateofpost-cureismuchlowerthantherateofitsreactiononelectronbeamtreatment.

简介：Withtheaidofthelatestfiberopticsensingtechnology,parametersinthecureprocessofthermosettingresin-matrixcomposite,suchastemperature,viscosity,voidandresidualstress,canbemonitoredentirelyandefficiently.Inthispaper,experimentresultsofviscositymeasurementincompositecureprocessinautoclaveusingfiberopticsensorsarepresented.Basedonthesensedinformation,acomputerprogramisutilizedtocontrolthecureprocess.Withthistechnology,thecureprocessbecomesmoreapparentandcontrollable,whichwillgreatlyimprovethecuredproductsandreducethecost.

简介：一系列聚合物混合从1,3二度(3,4-dicyanophenoxy)被准备苯(3BOCN)和有是的甲基tetrahydrophthalic酐的环氧基树脂树脂治好代理人。治好的行为和混合的治好的动力学被微分扫描热量测定学习。没有3BOCN，有3BOCN的各种各样的内容的混合的明显的激活精力比混合的高。一个模型实验建议在phthalonitrile和环氧基树脂之间没有明显的反应。聚合物混合的热、机械的性质被评估。聚合物混合与整洁的环氧基树脂相比展出高存储模量和字符产量。聚合物混合证明由扫描电子显微镜学(SEM)的可锻的破裂形态学想象。

简介：

简介：AbstractMany seminal advances have been made in human immunodeficiency virus (HIV)/AIDS research over the past four decades. Treatment strategies, such as gene therapy and immunotherapy, are yielding promising results to effectively control HIV infection. Despite this, a cure for HIV/AIDS is not envisioned in the near future. A recently published academic study has raised awareness regarding a promising alternative therapeutic option for HIV/AIDS, referred to as "selective elimination of host cells capable of producing HIV" (SECH). Similar to the "shock and kill strategy," the SECH approach requires the simultaneous administration of drugs targeting key mechanisms in specific cells to efficiently eliminate HIV replication-competent cellular reservoirs. Herein, we comprehensively review the specific mechanisms targeted by the SECH strategy. Briefly, the suggested cocktail of drugs should contain (i) latency reversal agents to promote the latency reversal process in replication-competent reservoir cells, (ii) pro-apoptotic and anti-autophagy drugs to induce death of infected cells through various pathways, and finally (iii) drugs that eliminate new cycles of infection by prevention of HIV attachment to host cells, and by HIV integrase inhibitor drugs. Finally, we discuss three major challenges that are likely to restrict the application of the SECH strategy in HIV/AIDS patients.

简介：AbstractHolmium laser lithotripsy (HLL) is one of the common surgical methods for urolithiasis. It causes minor surgical trauma, but complications are not rare. Extracorporeal membrane oxygenation (ECMO) treatment of sepsis is common, but venoarterial (VA)-ECMO treatment of urosepsis has not been reported yet. In this article, we reported a 67-year-old female patient with refractory septic shock caused by HLL under percutaneous nephroscope, involving breathing, heart, kidney and other organs, and organs support treatment was ineffective for the patient. Finally, we successfully treated the patient under VA-ECMO with continuous renal replacement therapy (CRRT). Combined ECMO and CRRT may provide a solution for addressing refractory sepsis. Here we present the case and review relevant literature, so as to provide a treatment strategy for patients with refractory urogenic sepsis and to reduce the mortality rate.